Source:http://linkedlifedata.com/resource/pubmed/id/14572159
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2003-10-23
|
pubmed:abstractText |
Methylenetetrahydrofolate reductase (MTHFR) is involved in folate metabolism and plays a role in DNA biosynthesis, methylation, and repair in actively dividing cells. A common 677C>T polymorphism in the gene for MTHFR, leading to a thermolabile enzyme with decreased activity, has been associated with reduced plasma folate levels and elevated homocysteine levels and could be a risk factor for breast cancer. In the present case-control study, MTHFR genotype was determined in 500 women with clinically verified breast cancer and 500 female age-matched healthy control subjects. The homozygous TT genotype was found in 13.0% patients and 13.1% controls (P = n.s.). The odds ratio of TT homozygotes for breast cancer was 0.99 (95% confidence interval 0.68-1.43). The MTHFR genotype was furthermore not associated with tumor size, histological grading, estrogen or progesterone receptor status and age at diagnosis. In a subgroup of 116 premenopausal patients, no increased frequency of the homozygous 677T genotype was found (13.8%). Therefore, we conclude that the MTHFR 677C>T polymorphism is not associated with individual susceptibility to breast cancer.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0167-6806
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
81
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
169-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14572159-Adult,
pubmed-meshheading:14572159-Aged,
pubmed-meshheading:14572159-Aged, 80 and over,
pubmed-meshheading:14572159-Breast Neoplasms,
pubmed-meshheading:14572159-Carcinoma, Ductal, Breast,
pubmed-meshheading:14572159-Case-Control Studies,
pubmed-meshheading:14572159-Cytosine,
pubmed-meshheading:14572159-Female,
pubmed-meshheading:14572159-Genotype,
pubmed-meshheading:14572159-Humans,
pubmed-meshheading:14572159-Methylenetetrahydrofolate Reductase (NADPH2),
pubmed-meshheading:14572159-Middle Aged,
pubmed-meshheading:14572159-Polymerase Chain Reaction,
pubmed-meshheading:14572159-Polymorphism, Genetic,
pubmed-meshheading:14572159-Risk Factors,
pubmed-meshheading:14572159-Thymine
|
pubmed:year |
2003
|
pubmed:articleTitle |
The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk.
|
pubmed:affiliation |
Department of Internal Medicine, Division of Oncology, Karl-Franzens University Graz, Graz, Austria. uwe.langsenlehner@klinikum-graz.at
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|